![Timothy Stubbs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Stubbs
Direktor/Vorstandsmitglied bei
BLOSSOMHILL THERAPEUTICS, INC.
Profil
Timothy Stubbs is Executive Director at Vivo Capital LLC since 2022.
Dr. Stubbs is Independent Director at Blossomhill Therapeutics, Inc. since 2024.
Dr. Stubbs was Vice President at Morgan Stanley from 2015 to 2022.
Dr. Stubbs completed an undergraduate degree at the University of Bristol in 2013.
Aktive Positionen von Timothy Stubbs
| Unternehmen | Position | Beginn |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2024 |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Private Equity Investor | 01.03.2022 |
Ehemalige bekannte Positionen von Timothy Stubbs
| Unternehmen | Position | Ende |
|---|---|---|
| MORGAN STANLEY | Corporate Officer/Principal | 01.03.2022 |
Ausbildung von Timothy Stubbs
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Finance |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
